Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-26-058713
Filing Date
2026-05-19
Accepted
2026-05-19 06:51:45
Documents
2
Period of Report
2026-05-19

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea0291476-6k_clearmind.htm 6-K 14689
2 FORM OF CONVERSION AGREEMENT ea029147601_ex99-1.htm EX-99.1 17592
  Complete submission text file 0001213900-26-058713.txt   33345
Mailing Address 101-1220 WEST 6TH AVENUE VANCOUVER, BRITISH COLUMBIA Z4 V6H1A5
Business Address 101-1220 WEST 6TH AVENUE VANCOUVER, BRITISH COLUMBIA Z4 V6H1A5 972-54-5704749
Clearmind Medicine Inc. (Filer) CIK: 0001892500 (see all company filings)

EIN.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1031
Type: 6-K | Act: 34 | File No.: 001-41557 | Film No.: 26995828
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)